FDA weighs first-ever OTC birth control pill
The Food and Drug Administration is reviewing a first-of-its-kind
application from HRA Pharma for Opill. If green-lit by the agency, Opill
would become the first daily, hormonal birth control pill sold without a
prescription. The submission of the application follows more than six
years of studies the company has run. Alice Miranda Ollstein reports.
application from HRA Pharma for Opill. If green-lit by the agency, Opill
would become the first daily, hormonal birth control pill sold without a
prescription. The submission of the application follows more than six
years of studies the company has run. Alice Miranda Ollstein reports.
The podcast POLITICO Tech is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.